BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 15363067)

  • 1. Role of insulin-like growth factor-I in the treatment of painful small fiber predominant neuropathy.
    Windebank AJ; Sorenson EJ; Civil R; O'Brien PC
    J Peripher Nerv Syst; 2004 Sep; 9(3):183-9. PubMed ID: 15363067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
    Chihara K; Kato Y; Kohno H; Takano K; Tanaka T; Teramoto A; Shimatsu A
    Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
    Simpson DM; Messina J; Xie F; Hale M
    Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C beta-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trial.
    Vinik AI; Bril V; Kempler P; Litchy WJ; Tesfaye S; Price KL; Bastyr EJ;
    Clin Ther; 2005 Aug; 27(8):1164-80. PubMed ID: 16199243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, double-blinded, placebo-controlled phase II trial of recombinant human leukemia inhibitory factor (rhuLIF, emfilermin, AM424) to prevent chemotherapy-induced peripheral neuropathy.
    Davis ID; Kiers L; MacGregor L; Quinn M; Arezzo J; Green M; Rosenthal M; Chia M; Michael M; Bartley P; Harrison L; Daly M
    Clin Cancer Res; 2005 Mar; 11(5):1890-8. PubMed ID: 15756015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor I (IGF-I) replacement therapy increases albumin concentration in liver cirrhosis: results of a pilot randomized controlled clinical trial.
    Conchillo M; de Knegt RJ; Payeras M; Quiroga J; Sangro B; Herrero JI; Castilla-Cortazar I; Frystyk J; Flyvbjerg A; Yoshizawa C; Jansen PL; Scharschmidt B; Prieto J
    J Hepatol; 2005 Oct; 43(4):630-6. PubMed ID: 16024131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of venlafaxine on ongoing and experimentally induced pain in neuropathic pain patients: a double blind, placebo controlled study.
    Yucel A; Ozyalcin S; Koknel Talu G; Kiziltan E; Yucel B; Andersen OK; Arendt-Nielsen L; Disci R
    Eur J Pain; 2005 Aug; 9(4):407-16. PubMed ID: 15979021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lacosamide in painful diabetic peripheral neuropathy: a phase 2 double-blind placebo-controlled study.
    Rauck RL; Shaibani A; Biton V; Simpson J; Koch B
    Clin J Pain; 2007 Feb; 23(2):150-8. PubMed ID: 17237664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Divalproex sodium in the management of post-herpetic neuralgia: a randomized double-blind placebo-controlled study.
    Kochar DK; Garg P; Bumb RA; Kochar SK; Mehta RD; Beniwal R; Rawat N
    QJM; 2005 Jan; 98(1):29-34. PubMed ID: 15625351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of lacosamide in diabetic neuropathic pain: an 18-week double-blind placebo-controlled trial of fixed-dose regimens.
    Wymer JP; Simpson J; Sen D; Bongardt S;
    Clin J Pain; 2009 Jun; 25(5):376-85. PubMed ID: 19454870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous immunoglobulin treatment for painful sensory neuropathy associated with Sjögren's syndrome.
    Morozumi S; Kawagashira Y; Iijima M; Koike H; Hattori N; Katsuno M; Tanaka F; Sobue G
    J Neurol Sci; 2009 Apr; 279(1-2):57-61. PubMed ID: 19168191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sativex successfully treats neuropathic pain characterised by allodynia: a randomised, double-blind, placebo-controlled clinical trial.
    Nurmikko TJ; Serpell MG; Hoggart B; Toomey PJ; Morlion BJ; Haines D
    Pain; 2007 Dec; 133(1-3):210-20. PubMed ID: 17997224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind, parallel-group, placebo-controlled, multicentre study of acetyl L-carnitine in the symptomatic treatment of antiretroviral toxic neuropathy in patients with HIV-1 infection.
    Youle M; Osio M;
    HIV Med; 2007 May; 8(4):241-50. PubMed ID: 17461852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short- and intermediate-term efficacy of buprenorphine TDS in chronic painful neuropathies.
    Penza P; Campanella A; Martini A; Melli G; Lombardi R; Camozzi F; Devigili G; Lauria G
    J Peripher Nerv Syst; 2008 Dec; 13(4):283-8. PubMed ID: 19192068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone secretagogue MK-677: no clinical effect on AD progression in a randomized trial.
    Sevigny JJ; Ryan JM; van Dyck CH; Peng Y; Lines CR; Nessly ML;
    Neurology; 2008 Nov; 71(21):1702-8. PubMed ID: 19015485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors that impact symptomatic diabetic peripheral neuropathy in placebo-administered patients from two 1-year clinical trials.
    Tesfaye S; Tandan R; Bastyr EJ; Kles KA; Skljarevski V; Price KL;
    Diabetes Care; 2007 Oct; 30(10):2626-32. PubMed ID: 17623822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.
    Arnold LM; Lu Y; Crofford LJ; Wohlreich M; Detke MJ; Iyengar S; Goldstein DJ
    Arthritis Rheum; 2004 Sep; 50(9):2974-84. PubMed ID: 15457467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulsed electromagnetic fields to reduce diabetic neuropathic pain and stimulate neuronal repair: a randomized controlled trial.
    Weintraub MI; Herrmann DN; Smith AG; Backonja MM; Cole SP
    Arch Phys Med Rehabil; 2009 Jul; 90(7):1102-9. PubMed ID: 19577022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dichloroacetate causes toxic neuropathy in MELAS: a randomized, controlled clinical trial.
    Kaufmann P; Engelstad K; Wei Y; Jhung S; Sano MC; Shungu DC; Millar WS; Hong X; Gooch CL; Mao X; Pascual JM; Hirano M; Stacpoole PW; DiMauro S; De Vivo DC
    Neurology; 2006 Feb; 66(3):324-30. PubMed ID: 16476929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.